arteriosclerosis obliterans
Information
- Disease name
- arteriosclerosis obliterans
- Disease ID
- DOID:5160
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT05083299 | Completed | Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate | January 28, 2020 | January 20, 2022 | |
NCT00712946 | Completed | Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages | March 2006 | December 2010 | |
NCT00823849 | Completed | Phase 4 | Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker | October 2008 | March 2010 |
NCT01518205 | Completed | N/A | HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F) | February 2012 | December 2015 |
NCT00145262 | Unknown status | TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation | August 2003 | ||
NCT02431234 | Unknown status | Arterial Calcification in the Diabetes | February 2014 | September 2018 | |
NCT02864654 | Unknown status | Phase 1/Phase 2 | Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia | July 2016 | July 2018 |
NCT02877173 | Unknown status | Phase 2 | A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans | August 2016 | December 2017 |
NCT00912756 | Unknown status | Phase 4 | Sufficient Treatment of Peripheral Intervention by Cilostazol | March 2009 | September 2012 |
- Disase is a (Disease Ontology)
- DOID:2349
- Cross Reference ID (Disease Ontology)
- MESH:D001162
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:60625000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0003851
- MeSH unique ID (MeSH (Medical Subject Headings))
- D001162